In a first for the agency under its modified risk tobacco product (MRTP) pathway, the FDA has approved eight snus smokeless tobacco products sold under the “General” brand name by Swedish Match AB’s (OTCPK:SWMAF) U.S. unit.
The approval allows the company to market the
products with the following statement: “Using General Snus instead of
cigarettes puts you at a lower risk of mouth cancer, heart disease, lung
cancer, stroke, emphysema, and chronic bronchitis.”
The products have been available in the U.S. since 2015 without modified risk claims.
https://seekingalpha.com/news/3507830-fda-oks-eight-swedish-match-modified-risk-smokeless-tobacco-products
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.